Psychiatry & Neurology Doctors in Auburn, ME Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Mitchell K Ross, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Minot Ave, Auburn, ME 04210 Phone: 207-795-2927    Fax: 207-795-2000

Dr. Hunter Lee William Sweet, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Minot Ave, Auburn, ME 04210 Phone: 207-795-2927

Mr. Ronald R Campbell, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Two Great Falls Plaza, #22, Auburn, ME 04210 Phone: 207-782-7640    Fax: 207-784-4868

Edward A Waybright, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 Minot Ave, Ste 404, Auburn, ME 04210 Phone: 207-795-2927    Fax: 207-795-2000

News Archive

Program to promote patients' overall health following kidney transplant surgery

Patient adherence after a kidney transplant, or faithfully following a prescribed medical regimen, is vital to a transplant recipient's health and the survival of their new organ.

Analysis: More progress needed before widespread adoption of healthcare value assessments

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of an analysis showing that while value assessment frameworks are moving closer to meeting the challenge of accurately measuring value and reliably informing healthcare decisions, more progress is needed before widespread adoption and use.

Study finds cord blood transplant recipients appear to have better outcomes against leukemia

Umbilical cord blood transplants may have advantages beyond offering an alternative stem cell source for leukemia patients without a traditional donor match, according to a study published today in The New England Journal of Medicine.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Ohr Pharmaceutical declares 1-for-3 reverse split of its outstanding common stock

Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.

Read more Medical News

› Verified 3 days ago